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Background: Accurate identification of hospitalizations for acute exacerbations of chronic 
obstructive pulmonary disease (AECOPD) within electronic health care records is important for 
research, public health, and to inform health care utilization and service provision. We aimed 
to develop a strategy to identify hospitalizations for AECOPD in secondary care data and to 
investigate the validity of strategies to identify hospitalizations for AECOPD in primary care data.
Methods: We identified patients with chronic obstructive pulmonary disease (COPD) in the 
Clinical Practice Research Datalink (CPRD) with linked Hospital Episodes Statistics (HES) data. 
We used discharge summaries for recent hospitalizations for AECOPD to develop a strategy to 
identify the recording of hospitalizations for AECOPD in HES. We then used the HES strategy 
as a reference standard to investigate the positive predictive value (PPV) and sensitivity of 
strategies for identifying AECOPD using general practice CPRD data. We tested two strategies: 
1) codes for hospitalization for AECOPD and 2) a code for AECOPD other than hospitalization 
on the same day as a code for hospitalization due to unspecified reason.
Results: In total, 27,182 patients with COPD were included. Our strategy to identify hospitaliza-
tions for AECOPD in HES had a sensitivity of 87.5%. When compared with HES, using a code 
suggesting hospitalization for AECOPD in CPRD resulted in a PPV of 50.2% (95% confidence 
interval [CI] 48.5%–51.8%) and a sensitivity of 4.1% (95% CI 3.9%–4.3%). Using a code for 
AECOPD and a code for hospitalization due to unspecified reason resulted in a PPV of 43.3% 
(95% CI 42.3%–44.2%) and a sensitivity of 5.4% (95% CI 5.1%–5.7%).
Conclusion: Hospitalization for AECOPD can be identified with high sensitivity in the HES 
database. The PPV and sensitivity of strategies to identify hospitalizations for AECOPD in 
primary care data alone are very poor. Primary care data alone should not be used to identify 
hospitalizations for AECOPD. Instead, researchers should use data that are linked to data from 
secondary care.
Keywords: validation, linked data, COPD, hospitalization, cause-specific hospitalization
Background
Chronic obstructive pulmonary disease (COPD) is a common progressive lung disease 
characterized by airflow obstruction, which is not fully reversible. In the UK, over 
1 million people have been diagnosed with COPD, with an estimated further 2 million 
remaining undiagnosed.1,2 People with COPD often have periods of acute worsening 
of symptoms beyond the normal day-to-day variation, which may require a change 
in the patient’s treatment; these episodes are known as acute exacerbations of COPD 
(AECOPD). On average, people with COPD experience around two AECOPD every 
year3 (including mild events), and AECOPD are important drivers of morbidity and 
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mortality.4–6 Most episodes of AECOPD are managed in 
primary care or by the patient; however, more severe events 
and/or events in patients with more severe disease or sig-
nificant comorbidities may require admission to hospital. 
Hospitalizations for AECOPD are serious events with around 
8%7 of those admitted dying in hospital and 23% dying 
within 1 year. As well as being important for individuals, as 
the second most common reason for emergency admission 
to hospital in the UK,8 they are also of great public health 
importance. Consequently, hospitalizations for AECOPD are 
a key outcome in clinical trials and observational studies in 
people with COPD.
Health care in the UK is mainly provided by the National 
Health Service (NHS), a public health care system. Primary 
health care in the NHS is provided by general practitioners 
(GPs), and over 98% of the UK population are registered with 
an NHS GP. In the UK, both data from primary care and data 
related to hospital admissions are readily available and are 
routinely used for research and for health service planning. 
With potentially very large sample sizes and representative 
and detailed real-life data, electronic health care records 
(EHRs) provide an excellent resource in which to conduct 
epidemiological studies, including disease epidemiology and 
comparative safety and effectiveness assessments of inter-
ventions. As well as observational studies, an exciting new 
area in electronic EHRs research is their use for recruitment 
and follow-up of patients in pragmatic clinical trials,9 and 
these will require valid definitions of important outcomes. 
In addition to research, EHRs can also be used in areas such 
as national audits of care and by commissioning groups to 
plan local services.
However, as routine electronic medical or health care 
records data are not collected for the purpose of research or 
audit, one potential limitation of these data is the accuracy 
and completeness of coded diagnoses. The Clinical Practice 
Research Datalink (CPRD) is a large database of data from 
UK primary care. One strength of the CPRD database is its 
linkages with other databases including Hospital Episodes 
Statistics (HES) data, an administrative database of all hos-
pital admissions in England.
CPRD has been used extensively for research. Many 
studies have investigated the validity of CPRD diagnoses 
for research use, and in general, these have been found to 
be high.10 For specific conditions, the validity of research 
using CPRD data will depend on both the validity of the 
algorithm that researchers use to identify the condition and 
the propensity for the condition to be missed, misrecorded, 
or misdiagnosed by GPs. Several others have found low 
completeness when using primary care records alone to 
identify cause-specific hospitalizations.11–13 One solution 
to this problem is to use primary care data, such as CPRD, 
linked to secondary care data, such as HES. When study-
ing hospitalized AECOPD, for practical reasons, this is not 
always done,14–16 and others have called for the recording 
hospitalizations for AECOPD in UK primary care data to be 
validated using HES as a reference standard.17
Our study had two aims: 1) to investigate sensitivity of 
recording of hospital admissions for AECOPD in UK second-
ary care administrative records (HES) and 2) to use linked 
primary and secondary care data (CPRD–HES) to assess the 
positive predictive value (PPV) and sensitivity of strategies to 
identify hospitalizations for AECOPD using primary care data.
Methods
Data sources
The CPRD is a very large clinical electronic EHR database 
of primary EHRs in the UK. It contains information on 
areas such as diagnoses, prescriptions, and test results, and 
some lifestyle data, such as smoking status and body mass 
index. Currently, there are data for over 11 million patients 
in CPRD, with 4.4 million of these being active patients 
(representing around 6.9% of the UK population).18 Much 
of the clinical data recorded in CPRD is in the form of Read 
codes. Read codes are a clinical classification system used 
to record diagnoses, symptoms, test results, lifestyle factors 
such as smoking, and other details of consultations. Some 
information about patient contacts with secondary care, such 
as referrals, emergency room visits, and hospital admissions 
may be also captured in CPRD. However, as this requires 
someone in the GP practice to manually enter such encoun-
ters, their recording may be incomplete.
HES is an administrative database containing informa-
tion on all episodes of admitted patient care in England 
requiring overnight stay in hospital; these inpatient data 
used for this study specifically exclude those only seen in 
accident and emergency department.19 Records for hospital 
admission in HES are split up into “finished consultant 
episodes (FCE)”, each of these represent an episode of care 
under a single consultant. Each hospital admission may be 
made up of several FCEs. FCE records contain information 
on up to 20 diagnoses recorded during that episode and 
are recorded using International Classification of Diseases 
(ICD, tenth edition) codes. As well as recording the reason 
for hospitalization, diagnoses recorded in HES may relate 
to coexistent comorbidities. In addition, there is a financial 
incentive for hospitals to accurately record comorbidities 
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during each hospitalization. The diagnostic code in the first 
position in the first FCE is commonly taken to be the reason 
for hospitalization.
CPRD practices based in England are eligible to be linked 
with HES data. Approximately 75% of English practices have 
consented to participate in this linkage, which equates to 
around 60% of the total CPRD population.18 Although much 
of CPRD is eligible to be linked, HES data are not automati-
cally made available to researchers as obtaining linked data 
requires further approvals. Many researches may therefore 
only use “standalone” primary care CPRD data.
Study population
The total study population consisted of patients in CPRD who 
had a validated diagnosis of COPD and who were eligible for 
linkage to HES. Briefly, COPD patients were aged 35 years 
or older, current or ex-smokers, had a validated diagnostic 
code suggesting COPD, and at least two prescriptions for a 
COPD medicine, one within 4 weeks of COPD diagnosis.20 
Patients were followed up from January 1, 2004, their date 
of COPD diagnosis, 35th birthday, or CPRD practice “up to 
standard” date, whichever was latest, to March 31, 2014, date 
of death, transfer out of practice, or practice last collection 
date, whichever was earliest.
Recording of hospitalizations for AECOPD in HES
A summary of the analytical approaches for each of the aims 
is presented in Figure 1. For the first aim, we used hospital 
discharge summaries to identify how hospitalizations for 
AECOPD are recorded in HES. Hospital discharge sum-
maries were available for a subset of patients (N=40) who 
were also included in two previous validation studies (one 
validating the recording of COPD and one validating the 
recording of AECOPD in CPRD).20,21 As part of these studies, 
GPs were contacted and asked to send material related to their 
patient’s COPD, including hospital discharge summaries, to 
investigators. Additional questionnaire data were available 
for 637 patients, of whom 40 had linkable HES data and 
discharge letters for an admission to hospital for AECOPD. 
We therefore obtained 40 discharge summaries for 40 patients 
who had linkable HES data. We used these summaries as a 
reference standard to estimate the sensitivity of the possible 
HES strategies to identify hospitalizations for AECOPD. 
First, ICD codes which could be used to record hospital-
izations for AECOPD in HES were prespecified: “J44.0” 
and “J44.1” as specific AECOPD codes, the code for lower 
respiratory tract infection (LRTI) “J22” and the code for 
COPD “J44.9”. Next, we visualized the diagnostic  position 
of each of the ICD codes used that might potentially be used 
to record hospitalizations for AECOPD. Then, we used these 
codes to create strategies that might relate to hospitalizations 
for AECOPD based on combinations of these codes being 
in the first position or in any position of FCE (Table 1). We 
then estimated the sensitivity of each of these strategies in 
identifying hospitalizations for AECOPD using hospital 
discharge summaries as the reference standard. Finally, we 
calculated the total number of events each of these strategies 
would identify if they were used in the sample.
Aim 2 – How are hospitalizations for AECOPD recorded in
primary care (CPRD)? 
St
ep
 1 Identify hospital
discharge
summaries for
hospitalizations
for AECOPD and
use this as a
reference
standard for
AIM 1
St
ep
 2 Identify how
these events are
recorded in HES  S
te
p 
3 Identify most
accurate strategy
in HES to identify
AECOPD in terms
of sensitivity and
number of
events  
St
ep
 4 Develop a priori
definitions of
hospitalization for
AECOPD in  
CPRD data only 
St
ep
 5 Use most
accurate strategy
in step 3 to
identify
hospitalizations
for AECOPD in
HES and use this
as a reference
standard for
Aim 2
St
ep
 6 Investigate the
accuracy of using
CPRD records only
to identify
AECOPD in terms
of PPV and
sensitivity    
Aim 1 – How are hospitalizations for AECOPD recorded in
secondary care (HES)? 
Figure 1 Summary of the methods for each of the aims of the study.
Abbreviations: AECOPD, acute exacerbations of chronic obstructive pulmonary 
disease; CPRD, Clinical Practice Research Datalink; HES, Hospital Episodes Statistics; 
PPV, positive predictive value.
Table 1 Strategies for identifying admissions to hospital for 
AECOPD in HES
HES definition of AECOPD hospitalization
1.   Specific AECOPD code or COPD code in any position in any FCE 
during spell
2.   Specific AECOPD code in any position or COPD code in first 
position in any FCE during spell
3.  Specific AECOPD code in any position in any FCE during spell
4.   Specific AECOPD code in any position in or LRTI code or COPD 
code in first position in any FCE during spell
5.   Specific AECOPD code or LRTI code in any position or COPD code 
in first position in any FCE during spell
6.  Specific AECOPD code in first position in first FCE during spell
Abbreviations: COPD, chronic obstructive pulmonary disease; AECOPD, acute 
exacerbations of COPD; LRTI, lower respiratory tract infection; HES, Hospital 
Episodes Statistics; FCE, finished consultant episodes.
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Recording of hospitalizations for AECOPD in CPRD
For the second aim, we identified strategies that might be used 
to identify hospitalizations for AECOPD in standalone pri-
mary care records. Broadly, there were two strategies: 1) pres-
ence of a code that suggested hospitalization for AECOPD 
and 2) presence of a code or codes on the same day, which 
suggested that the patient both had an AECOPD and had 
been admitted to hospital. To identify records for AECOPD 
in CPRD, we used our previously validated algorithm.21 We 
did not include codes suggesting pneumonia in either of these 
strategies, as although AECOPD may be (incorrectly) coded 
using these codes, they are unlikely to be used in a strategy 
to identify hospitalizations for AECOPD for research pur-
poses. Furthermore, we searched the Read code dictionary 
for codes that suggested hospitalization for AECOPD or for 
hospitalization without a specified reason. These strategies 
are summarized in Table 2. We also removed dates that were 
coded as COPD “annual review” dates as we have previously 
demonstrated that AECOPD codes are used at these times 
despite these not being acute episodes of AECOPD.21
To test the validity of different strategies to identify hospi-
talizations for AECOPD in primary care data, we calculated 
the PPV and sensitivity of strategies listed in Table 2 using 
HES-recorded hospitalization for AECOPD as the reference 
standard. For the estimation of PPV, we looked backward in 
the HES record for 30 days following a potential AECOPD 
hospitalization in CPRD; for sensitivity, we looked forward 
in the CPRD patient record 30 days after the HES-recorded 
hospital admission to allow for any delays in recording in 
the GP surgery. As an additional analysis, we increased this 
window to 60 days. We repeated these analyses stratified by 
different predefined definitions of HES-recorded hospitaliza-
tion for AECOPD (definitions 1, 3, and 5 in Table 1).
We conducted an additional analysis to investigate other 
ways in which hospitalizations for AECOPD may be coded 
that would not have been picked up by either of the strategies 
that we developed. To accomplish this goal, we investigated 
the PPV and sensitivity of just using either a code or codes 
which suggested the patient had an AECOPD or had been 
to hospital in identifying hospitalizations for AECOPD (eg, 
“admission to hospital” alone or “LRTI” alone), ie, when 
there was information that the COPD patient had either 
a) been to hospital for an unspecified reason or b) had an 
AECOPD but no code to suggest that the patient had been 
to hospital. As admission to hospital may also be recorded 
by GPs using “consultation types” and “referral types” rather 
than separate Read codes, we also extended the CPRD defini-
tion of an AECOPD code on the same day as a hospitalization 
code to include these consultation types and referral types, 
and then assessed this extended definition against our main 
HES definition of hospitalization for AECOPD. In addition, 
we also explored a random sample of 100 Read codes pres-
ent on days in which there was a record for a hospitalization 
for AECOPD in HES and were not associated with codes 
for AECOPD or hospitalizations. Statistical analysis was 
conducted in Stata 14.1 MP (StataCorp LP, College Station, 
TX, USA) and R 3.2.3.
Ethics approval
Ethics approval was obtained from the London School of 
Hygiene and Tropical Medicine Observational Research 
Ethics Committee (approval number 6481) and the CPRD 
Independent Scientific Advisory Committee (approval num-
ber 13_116A). Patient records and questionnaire responses 
were deidentified and anonymized by CPRD staff before 
being sent to the investigators. The  Independent Scientific 
Advisory Committee protocol is available on request. Further 
patient consent was not required due to the nature of the study.
Results
In total, 27,182 COPD patients with linked HES–CPRD 
data were included in the initial cohort after fulfilling 
inclusion criteria (Figure 2). The characteristics of patients 
included in the study are summarized in Table 3. In the total 
cohort, the mean age was 65.5 years (standard deviation: 
11.1), 46.5% were females, and 59.7% current smokers. 
About 54.4% had moderate-to-severe dyspnea (Medical 
Research Council ≥3), and 36.4% had GOLD grade of 
airflow  limitation 3 or higher.
Recording of hospitalizations for 
AECOPD in HES
Graphs demonstrating the diagnostic positions of ICD 
codes in HES for AECOPD, LRTI, and COPD in FCE for 
Table 2 Possible strategies for identifying hospitalizations for 
AECOPD using primary care data alone
Definition Example
Diagnostic code or codes suggesting 
hospitalization for AECOPD
“Admit COPD emergency”
Diagnostic code(s) suggesting AECOPD 
(using our previously validated algorithm) 
and nonspecific code(s) suggesting  
admission to hospital on the same day
“Acute LRTI” and 
“admission to hospital” on 
the same day
Abbreviations: COPD, chronic obstructive pulmonary disease; AECOPD, acute 
exacerbations of COPD; LRTI, lower respiratory tract infection.
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Recording of hospitalizations for AECOPD
 hospitalized COPD patients are shown in Figure 3. These 
graphs  demonstrate that codes for AECOPD and LRTI tend 
to be used in the first position. The code for COPD, although 
it is commonly used in the first position, is also often used 
in subsequent positions.
The findings for the investigation of the validity of the 
strategies used to identify hospitalizations for AECOPD are 
presented in Table 4. For the assessment of sensitivity, 40 dis-
charge letters were available. The lowest estimated sensitivity 
was definition 6, using only a specific AECOPD code in the 
first position in the first FCE for a hospitalization (sensitivity 
65.0%, 95% confidence interval [CI] 45.8%–78.6%). The 
highest estimated sensitivity was definition 5, using either 
a specific AECOPD code or an LRTI code in any position 
or a COPD code in the first position in any FCE during a 
hospitalization (sensitivity: 87.5%, 95% CI: 72.4%–94.9%).
Recording of hospitalizations for 
AECOPD in primary care records
Using the most sensitive definition of AECOPD hospitaliza-
tion identified in HES as the reference standard, the PPV 
for the specific AECOPD hospitalization code in CPRD 
was 50.2% (95% CI: 48.5%–51.8%) and the sensitivity 
was 4.1% (95% CI: 3.9%–4.3%) (Table 5). Using AECOPD 
identified using the previously validated algorithm on the 
same day as a Read code suggesting hospitalization due to 
unspecified reason in the primary care record resulted in a 
PPV of 43.3% (95% CI: 42.3%–44.2%) and a sensitivity 
of 5.4% (95% CI: 5.1%–5.7%). The use of different HES 
definitions of hospitalization for AECOPD did not result 
in markedly different results (Table 5). The results of the 
Patients included in the main
analysis 
N=27,182 
Patients eligible 
N=27,182 
Excluded:
Not linked with HES 
Patients with diagnosis of COPD in
CPRD with at least two prescriptions
of a COPD medicine (one within 4
weeks of COPD index date)
N=46,025
N=18,843
Figure 2 Flow of patients through the study.
Abbreviations: COPD, chronic obstructive pulmonary disease; CPRD, Clinical 
Practice Research Datalink; HES, Hospital Episodes Statistics.
Table 3 Characteristics of patients included in the study
Characteristic Overall Those with 
hospital discharge 
information
N=27,182 (N [%]) N=40 (N [%])
Age group (years)
  ≤55 5,003 (18.4) 7 (17.5)
 55–64 7,746 (28.5) 16 (40.0)
 65–74 8,537 (31.4) 12 (30.0)
 ≥75 5,896 (21.7) 5 (12.5)
Sex
 Male 14,556 (53.6) 18 (45.0)
MRC breathlessness  
scale (kg/m2; N=21,151)
 <3 9,645 (45.6) 21 (53.8)
 ≥3 11,506 (54.4) 18 (46.2)
BMI (N=26,447)
 <19 1,441 (5.5) 1 (2.5)
 19–25 9,568 (36.2) 18 (45.0)
 ≥25 15,438 (58.4) 21 (52.5)
GOLD 2006 grade 
(N=14,055)
 1 2,829 (20.1) 4 (16.7)
 2 6,116 (43.5) 6 (25.0)
 3 4,075 (29.0) 10 (41.7)
 4 1,035 (7.4) 4 (16.7)
Smoking status
 Ex-smoker 10,963 (40.3) 19 (47.5)
 Current smoker 16,219 (59.7) 21 (52.5)
Index of multiple 
deprivation quintile 
(N=25,852)
 1 (least deprived) 3,632 (14.1) 8 (20.0)
 2 5,259 (20.3) 7 (17.5)
 3 4,989 (19.3) 7 (17.5)
 4 5,794 (22.4) 6 (15.0)
 5 (most deprived) 6,178 (23.9) 12 (30.0)
Abbreviations: MRC, Medical Research Council; BMI, body mass index; GOLD, 
Global Initiative for Chronic Obstructive Lung Disease.
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Figure 3 Diagnostic positions of ICD codes for AECOPD, LRTIs, and COPD in Hospital Episodes Statistics records for hospitalizations for COPD patients.
Abbreviations:  ICD,  International  Classification  of  Diseases;  COPD, chronic obstructive pulmonary disease; AECOPD, acute exacerbations of COPD; LRTI, lower 
respiratory tract infection.
additional analysis repeated using only the day of the HES 
recorded event and using a 60-day window rather than 
a 30-day window following the HES recorded event are 
presented in the (Tables S1– S5). With the exception of an 
increase in the sensitivity of use of AECOPD code alone or 
nonspecific hospitalization code alone as the window was 
increased, these results did not differ significantly from the 
analysis using a 30-day window.
When the definition using AECOPD codes on the same 
day as hospitalization codes was extended to use consultation 
or referral types indicating hospitalization, this reduced the 
PPV to 14.6% (95% CI: 14.2%–14.9%) and increased the 
sensitivity to 6.0% (95% CI: 5.7%–6.3%). In the additional 
analysis to investigate the use of either a code or codes sug-
gesting AECOPD or hospitalization for any reason, the use 
of the AECOPD algorithm alone resulted in a PPV of 1.8% 
(95% CI: 1.7%–1.8%) and a sensitivity of 34.2% (95% CI: 
33.7%–34.6%). The use of a code suggesting hospitalization 
alone resulted in a PPV of 14.5% (95% CI: 14.3%–14.6%) and 
a sensitivity of 53.5% (95% CI: 53.0%–54.0%). These results 
repeated using different HES definitions for hospitalization 
due to AECOPD are presented in the (Tables S1, S3 and S5).
When assessing a random sample of 100 Read codes on 
the day of admission on which patients had a HES hospitaliza-
tion for AECOPD (after excluding codes that either suggested 
AECOPD according to our algorithm, or hospitalization for 
any reason), we found many of these related to nonspecific 
Read Terms suggesting patient contact such as “had a chat 
to patient”, “patient reviewed”, and “seen in out-of-hours 
center” (N=41); several related to recording of either heart 
rate or blood pressure (N=16); some related to contact with 
secondary care (but not necessarily suggesting admission to 
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hospital), such as “seen by respiratory physician” or “letter 
from specialist” (N=10); few related to symptoms of an 
AECOPD such as “cough” (N=5); the remaining (N=28) 
were not specific for AECOPD.
Discussion
We developed a valid strategy to identify hospitalizations for 
AECOPD using HES-linked CPRD data. Using this defini-
tion as a reference standard, we found that using informa-
tion from primary care data alone resulted in low PPV and 
sensitivity for identifying hospitalizations for AECOPD.
When we assessed the validity of the recording of 
hospitalizations for AECOPD in HES, we found that the 
most sensitive strategy was the use of a specific AECOPD 
or LRTI ICD-10 code in any position in any FCE, or the 
COPD ICD-10 code in the first position only in any FCE in 
a hospitalization (sensitivity 87.5%). The use of the COPD 
ICD-10 code in any position results in a very large number 
of events, and this likely represents it being used to record 
COPD as a comorbidity not as a reason for hospitalization. 
Although the exact definition used in future studies may 
differ depending on the needs of the study, this definition is 
likely to represent the “optimal” way to identify hospitaliza-
tions for AECOPD in HES. Restricting the definition to the 
specific AECOPD codes in the first position only in the first 
FCE reduced the sensitivity to around 65%. The failure to 
Table 4 Validity of HES definitions of AECOPD hospitalization
Discharge summary analysis Full HES sample analysis
HES definition of AECOPD  
hospitalization
Number of discharge 
summary-confirmed 
AECOPD hospitalizations 
identified using strategy 
(N=40 events in 40 patients 
from discharge letters)
Sensitivity (95% CI) (% of  
discharge summary-confirmed 
AECOPD hospitalizations 
picked up) (N=40 events in 
40 patients from discharge 
letters)
Number of potential AECOPD 
hospitalization events in total 
sample identified using strategy 
(full HES sample for all 27,182 
COPD patients included in the 
study)a
Specific AECOPD code or LRTI code  
in any position or COPD code in the  
first position in any FCE during spell
35/40 87.5% (72.4%–94.9%) 40,174
Specific AECOPD code or COPD code  
in any position in any FCE during spell
34/40 85.0% (69.6%–93.3%) 74,590
Specific AECOPD code in any position  
or LRTI code or COPD code in the  
first position in any FCE during spell
34/40 85.0% (69.6%–93.3%) 37,966
Specific AECOPD code in any position  
or COPD code in the first position in  
any FCE during spell
31/40 77.5% (61.3%–88.2%) 35,793
Specific AECOPD code in any position  
in any FCE during spell
31/40 77.5% (61.3%–88.2%) 33,933
Specific AECOPD code in the first 
position in first FCE during spell
26/40 65.0% (48.5%–78.6%) 21,387
Note: aThese potential events will represent both true and false positives.
Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; AECOPD, acute exacerbations of COPD; LRTI, lower respiratory tract infection; 
HES, Hospital Episodes Statistics; FCE, finished consultant episodes.
Table 5 PPV and sensitivity of CPRD strategies to identify hospitalizations for AECOPD using different HES definitions as reference 
standard allowing 30 days after HES record of hospitalization for AECOPD
HES AECOPD definition CPRD strategy PPV (95% CI) Sensitivity (95% CI)
AECOPD hospitalization or LRTI code in any 
position or COPD in the first position in any  
FCE
AECOPD hospitalization code 50.2% (48.5%–51.8%) 4.1% (3.9%–4.3%)
AECOPD identified using validated algorithm  
and hospitalization code
43.3% (42.3%–44.2%) 5.4% (5.1%–5.7%)
Either specific AECOPD code in any position  
or COPD code in the first position
AECOPD hospitalization code 49.0% (47.3%–50.6%) 4.6% (4.5%–4.9%)
AECOPD identified using validated algorithm  
and hospitalization code
38.5% (37.6%–39.4%) 5.5% (5.2%–5.9%)
Either specific AECOPD code in the first  
position in any FCE
AECOPD hospitalization code 45.9% (44.2%–47.6%) 4.7% (4.4%–4.9%)
AECOPD identified using validated algorithm  
and  hospitalization code
37.2% (36.3%–38.1%) 5.7% (5.4%–6.0%)
Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; AECOPD, acute exacerbations of COPD; LRTI, lower respiratory tract infection; 
HES, Hospital Episodes Statistics; FCE, finished consultant episodes; CPRD, Clinical Practice Research Datalink; PPV, positive predictive value.
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recognize the remaining patients is likely to represent COPD 
patients receiving a nonspecific ICD-10 code such as “short-
ness of breath” on an assessment ward before being moved 
to a specialist ward.
For the analysis of the accuracy of using primary care 
data only to identify hospitalized AECOPD, using the most 
sensitive HES definition of AECOPD as the reference 
standard, the maximum PPV achievable was 50.2% and the 
maximum sensitivity achievable was only 5.4%. The use 
of such strategies to identify hospitalizations for AECOPD 
would mean that the vast majority of “true” events would 
not be picked up, and that of those events which were 
picked up, only half would be “true” events. The findings 
from our additional analysis suggest that GPs are recording 
the majority of AECOPD hospitalizations simply by using 
generic hospitalization codes and/or AECOPD codes alone. 
The use of consultation and referral type data increased the 
sensitivity very slightly, but resulted in a large decrease in 
PPV. Although the use of nonspecific hospitalization codes 
or AECOPD codes alone had a higher sensitivity, particularly 
when the window was extended to 60 days, the PPV was very 
low and it is unclear if these relate to the index HES recorded 
event or further moderate AECOPD or hospitalizations. For 
the other CPRD definitions of AECOPD hospitalization, 
increasing the window beyond 60 days may have improved 
performance, but it would become difficult to differentiate 
multiple hospitalizations from each other. The findings from 
the examination of Read codes on days on which AECOPD 
hospitalizations occurred but were not identified by any of 
the CPRD strategies suggest that on the day of hospitaliza-
tion, many AECOPD hospitalizations are also recorded using 
even less specific codes than a generic hospitalization code. 
This is of clinical concern given the impact of first, and sub-
sequent, admission to hospital for AECOPD on prognosis in 
COPD patients.22
Our finding that validity of primary care recorded hos-
pitalizations for AECOPD is low is certainly striking, but 
perhaps not surprising. Previous works in cause-specific 
hospitalization in other disease areas have produced simi-
lar results. Recent studies investigating the validity and 
completeness of UK primary care recording of admission 
to hospital for acute myocardial infarction,13 poisonings, 
fractures and burns,11 and gastrointestinal bleeding12 have 
all found that strategies to identify these events in primary 
care tend to have low–moderate sensitivity and varying levels 
of PPV. In addition, a recent study showed that using HES-
linked CPRD data, rather than CPRD data alone, resulted in 
a doubling of incidence of community-acquired pneumonia 
and that this could be attributable to patients presenting 
directly to hospital without first consulting their GP.23 These 
findings are consistent with our results. A recent study did 
find a high PPV for codes suggesting hospital admission for 
community-acquired pneumonia in the general population, 
but this was only after restricting for those with a recent 
nonspecific respiratory infection code, and this study did 
not assess sensitivity.24 Interestingly, another study in UK 
primary care records found an increasing trend toward cod-
ing episodes of influenza-like illness (ILI) using nonspecific 
codes rather than definite ILI codes, and a tendency not to 
use definite ILI codes in populations in whom there was 
more likely to be diagnostic uncertainty.25 These findings 
are reflected in our results. The reasons that the PPV and 
sensitivity of the recording in primary care of hospitalizations 
for AECOPD are particularly low are likely to be: the use 
of nonspecific codes, diagnostic uncertainty, and the use of 
apparently acute codes to record historical events. Our find-
ings from this analysis are in stark contrast to our validation of 
the recording of AECOPD treated in general practice, where 
we found high PPV and adequate sensitivity.21
EHRs are becoming increasingly used both for research 
and for audit and service planning. Due to its universal public 
health care system, the UK is an attractive setting to use 
electronic EHRs to study diseases and medical interventions. 
Although GPs should be informed when their patients are 
admitted to hospital, this may not be recorded in such a way 
that is useful for researchers. Just as details such as comor-
bidities, prior medicine use, and sociodemographic details 
might be missing from secondary care records, detailed 
information about hospital admissions may be missing from 
primary care records. The present study underlines previous 
findings that hospital admission diagnoses and procedures 
are not consistently recorded in primary care. Although 
this may reduce sample sizes and result in a lag in avail-
able linked data, it seems that, for some conditions, use of 
primary care data alone may not result in valid definitions 
when used to study events, which may result in admission 
to hospital. Although the validity of definitions will likely 
differ between different conditions, researchers should be 
cautious about using primary care data alone to define cause-
specific hospitalizations.
The major strength of this study is the size and repre-
sentativeness of the sample. We used data for over 27,182 
COPD patients. Our assessment of the validity of the HES 
definitions of AECOPD hospitalization was only based on 
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40 patients, however, which may have affected the precision 
of the sensitivity estimates for the HES definitions. We also 
made use of a validated strategy to identify patients with 
COPD in the CPRD. Although there is some uncertainty in 
the best definition of hospitalization for AECOPD in HES 
to use as the reference standard, we used hospital discharge 
summaries to validate how these were recorded in HES. In 
addition, we repeated our main analysis using several dif-
ferent HES definitions of hospitalization for AECOPD, and 
these did not change our conclusions.
One weakness of the study is that the HES strategy did 
not identify all the hospitalizations for AECOPD and that 
we could not assess the PPV of the HES strategy; however, 
in the main analysis, we used a strategy with a sensitivity 
of 87.5%, and this is unlikely to have impacted on the con-
clusions of the study. In addition, although we were able to 
assess the sensitivity of the strategies to identify hospitaliza-
tions for AECOPD in HES, we were unable to assess their 
PPV. Imperfect PPV of the definition of hospitalizations for 
AECOPD in HES would have the effect of underestimating 
the sensitivity of CPRD algorithms. Using a range of hypo-
thetical PPVs, we can estimate the potential effect of lower 
PPV of the HES definitions by multiplying the estimated 
sensitivity of the CPRD definitions by the inverse of the PPV 
(1/hypothetical PPV). For example, if the PPV of our main 
HES definition was only 80%, the sensitivity of the CPRD 
definition using AECOPD hospitalization codes would only 
rise from 4.1% to 5.1%; and the algorithm using an AECOPD 
code and a hospitalization code on the same day would rise 
to 6.8%. Even in the unlikely situation that the PPV of our 
main HES algorithm was as low as 60%, the respective 
sensitivities would only increase to 6.8% for an AECOPD 
hospitalization code and 9.0% for an AECOPD code and 
hospitalization code on the same day. We also assessed the 
CPRD definitions of hospitalization for AECOPD using 
several definitions of AECOPD hospitalizations in HES, 
and the findings did not change when we used definitions 
with varying sensitivities. The impact of this limitation is 
therefore likely to be small.
Conclusion
In the UK, primary care EHR data should not be used alone to 
identify hospitalizations for exacerbations of COPD. To accu-
rately identify hospitalizations for AECOPD and to correctly 
classify AECOPD either as those treated in primary care or 
resulting in hospitalization, researchers should use primary 
care data linked with secondary care data on hospitalizations.
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Supplementary material
Table S3 PPV and sensitivity of record of AECOPD or nonspecific hospitalization code to identify hospitalizations for AECOPD using 
different HES definitions as reference standard allowing 30 days after HES record of hospitalization for AECOPD
HES AECOPD definition CPRD strategy PPV (95% CI) Sensitivity (95% CI)
AECOPD hospitalization code or LRTI code in any  
position or COPD code in first position in any FCE
AECOPD identified using algorithm 1.8% (1.7–1.8) 34.2% (33.7–34.6)
Nonspecific hospitalization code 14.5% (14.3–14.6) 53.5% (53.0–54.0)
Either specific AECOPD code in any position or COPD 
code in the first position
AECOPD identified using algorithm 1.5% (1.5–1.6) 34.6% (34.1–35.1)
Nonspecific hospitalization code 12.6% (12.5–12.8) 54.1% (53.6–54.6)
Either specific AECOPD code in the first position in  
any FCE
AECOPD identified using algorithm 1.5% (1.4–1.5) 35.1% (34.6–35.6)
Nonspecific hospitalization code 12.0% (11.9–12.2) 54.8% (54.3–55.3)
Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; AECOPD, acute exacerbations of COPD; LRTI, lower respiratory tract infection; 
HES, Hospital Episodes Statistics; FCE, finished consultant episodes; CPRD, Clinical Practice Research Datalink; PPV, positive predictive value.
Table S4 PPV and sensitivity of CPRD strategies to identify hospitalizations for AECOPD using different HES definitions as reference 
standard allowing 60 days after HES record of hospitalization for AECOPD
HES AECOPD definition CPRD strategy PPV (95% CI) Sensitivity (95% CI)
AECOPD hospitalization code or LRTI code in any  
position or COPD in the first position in any FCE
AECOPD hospitalization code 50.7% (49.1–52.3) 4.4% (4.3–4.6)
AECOPD identified using validated 
algorithm and hospitalization code
46.1% (44.3–47.8) 6.1% (5.8–6.4)
Either specific AECOPD code in any position or COPD 
code in the first position
AECOPD hospitalization code 49.5% (48.0–51.1) 5.0% (4.8–5.3)
AECOPD identified using validated 
algorithm and hospitalization code
41.2% (39.5–42.9) 6.2% (5.9–6.6)
Either specific AECOPD code in the first position in  
any FCE
AECOPD hospitalization code 46.6% (45.0–48.2) 5.0% (4.8–5.3)
AECOPD identified using validated 
algorithm and hospitalization code
39.5% (37.8–41.2) 6.4% (6.1–6.8)
Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; AECOPD, acute exacerbations of COPD; LRTI, lower respiratory tract infection; 
HES, Hospital Episodes Statistics; FCE, finished consultant episodes; CPRD, Clinical Practice Research Datalink; PPV, positive predictive value.
Table S1 PPV and sensitivity of CPRD strategies to identify hospitalizations for AECOPD using different HES definitions as reference 
standard using day of admission in HES only
HES AECOPD definition CPRD strategy PPV (95% CI) Sensitivity (95% CI)
AECOPD hospitalization or LRTI code in any position  
or COPD code in the first position in any FCE
AECOPD identified using algorithm 0.7% (0.7–0.7) 7.2% (6.95–7.6)
Nonspecific hospitalization code 10.3% (10.1–10.6) 27.1% (26.5–27.7)
Either specific AECOPD code in any position or COPD 
code in the first position
AECOPD identified using algorithm 0.6% (0.6–0.6) 7.2% (6.9–7.6)
Nonspecific hospitalization code 9.1% (8.9–9.3) 27.6% (27.0–28.2)
Either specific AECOPD code in the first position in  
any FCE
AECOPD identified using algorithm 0.6% (0.6–0.6) 7.4% (7.1–7.9)
Nonspecific hospitalization code 8.7% (8.5–8.9) 28.1% (27.4–28.7)
Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; AECOPD, acute exacerbations of COPD; LRTI, lower respiratory tract infection; 
HES, Hospital Episodes Statistics; FCE, finished consultant episodes; CPRD, Clinical Practice Research Datalink; PPV, positive predictive value.
Table S2 PPV and sensitivity of CPRD strategies to identify hospitalizations for AECOPD using different HES definitions as reference 
standard using day of admission in HES only
HES AECOPD definition CPRD strategy PPV (95% CI) Sensitivity (95% CI)
AECOPD hospitalization code or LRTI code in any  
position or COPD in the first position in any FCE
AECOPD hospitalization code 47.6% (44.3–50.8) 1.9% (1.7–2.0)
AECOPD identified using validated 
algorithm and hospitalization code
41.9% (39.8–44.0) 3.7% (3.5–4.0)
Either specific AECOPD code in any position or COPD 
code in the first position
AECOPD hospitalization code 43.6% (40.5–46.9) 2.1% (1.9–2.3)
AECOPD identified using validated 
algorithm and hospitalization code
36.8% (34.7–38.9) 3.7% (3.5–4.0)
Either specific AECOPD code in the first position in  
any FCE
AECOPD hospitalization code 46.5% (44.9–48.2) 2.1% (1.9–2.3)
AECOPD identified using validated 
algorithm and hospitalization code
35.3% (33.2–37.4) 3.8% (3.5–4.1)
Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; AECOPD, acute exacerbations of COPD; LRTI, lower respiratory tract infection; 
HES, Hospital Episodes Statistics; FCE, finished consultant episodes; CPRD, Clinical Practice Research Datalink; PPV, positive predictive value.
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Table S5 PPV and sensitivity of record of AECOPD or nonspecific hospitalization code to identify hospitalizations for AECOPD using 
different HES definitions as reference standard allowing 60 days after HES record of hospitalization for AECOPD
HES AECOPD definition CPRD strategy PPV (95% CI) Sensitivity (95% CI)
AECOPD hospitalization code or LRTI code in any  
position or COPD in the first position in any FCE
AECOPD identified using algorithm 2.3% (2.3–2.3) 46.3% (45.8–46.7)
Nonspecific hospitalization code 14.5% (14.4–14.7) 55.9% (55.4–56.4)
Either specific AECOPD code in any position or COPD 
code in the first position
AECOPD identified using algorithm 2.0% (2.0–2.1) 46.8% (46.3–47.3)
Nonspecific hospitalization code 12.7% (12.5–12.9) 56.5% (56.0–57.0)
Either specific AECOPD code in the first position in  
any FCE
AECOPD identified using algorithm 1.9% (1.9–1.9) 47.3% (46.8–47.8)
Nonspecific hospitalization code 12.1% (11.9–12.2) 57.2% (56.6–57.7)
Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; AECOPD, acute exacerbations of COPD; LRTI, lower respiratory tract infection; 
HES, Hospital Episodes Statistics; FCE, finished consultant episodes; CPRD, Clinical Practice Research Datalink; PPV, positive predictive value.
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